Evidence-based evaluation of drug gene studies in Chinese patients with epilepsyYANG Chun-song, WANG Yan-mei, ZHANG Ling-li, YU Dan259-262
Simultaneous determination of six main constituents in Jinsangsanjie capsules by HPLC gradient elutionTAN Xiong-si, PANG Wu-yao263-266
The determination of licarbazepine concentration in patients' plasma by RP-HPLCZHANG Guo-yang, HE Yin-zhou, WANG Li267-270
Quality standard studies of TongnaoyeWANG Xiu-qin, QIAN Qiu-yu, WANG Dong-xing, SHI Lei, CHEN Jun271-274
Pharmaceutical care on a patient with dilated cardiomyopathy and heart failureLI Yan-jiao, YAN Hui-yu, SONG Yan-qing275-277
Pharmaceutical care on the anticoagulant therapy of a patient with pulmonary embolism after melanoma resectionCAO Chang, SHI Tao, WANG Zhuo, ZHANG Wen-jing278-280,326
Analysis and consideration of pharmaceutical care on the patient with pulmonary heart disease by clinical pharmacistWANG Yan-li, JIAO Ping, ZHU Man281-284
Analysis of fluoroquinolones related neurological adverse reactions based on data mining methodsYANG Hong-yi, JIA Wang-ping, GUO Dai-hong, FAN Qi, ZHAO Su-yu285-288,320
Analysis on 9819 cases of ADR/ADE associated with quinolones in military hospitalsHUANG Cui-li, GUO Dai-hong, ZHU Man, WU Xu, SU Chang, ZHAO Su-yu, MA Liang, ZHAO Peng-zhi, ZHAO Liang293-296